Kyntra Bio Inc

0IL8.L | Healthcare | LSE
$8.26
+0.35 (+4.43%)

Key Metrics

Market Cap
$33.39M
P/E Ratio
-2.72
EPS
$-3.04
Beta
N/A
Dividend Yield
N/A
ROE
-126.39%
Current Ratio
3.71

Company Information

Industry
Medical Pharmaceuticals

About Kyntra Bio Inc

Kyntra Bio Inc is a biopharmaceutical company which engages in the discovery development and commercialization of novel therapeutics It focuses on the hypoxiainducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia fibrotic disease and cancer The company was founded by Thomas B Neff on September 29 1993 and is headquartered in San Francisco CA

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-11-10 $49.61 $-4.01 +-1,338.1%
2025-08-11 $-1.88 $-2.30 +-18.3%
2025-05-12 $1.25 $0.75 +66.7%
2025-03-17 $0.18 $-0.14 +-227.4%

Financial Ratios (TTM)

Gross Margin
82.74%
Operating Margin
105.04%
Net Margin
-182.61%
ROA
157.40%
Price to Book
-1.95
Price to Sales
-0.28